Brian L Durkin is VP, CONTROLLER of AbbVie Inc.. Currently has a direct ownership of 33,149 shares of ABBV, which is worth approximately $6.5 Million. The most recent transaction as insider was on Feb 28, 2023, when has been sold 11,182 shares (Common Stock, $0.01 par value) at a price of $154.28 per share, resulting in proceeds of $1,725,158. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.1K
0% 3M change
0% 12M change
Total Value Held $6.5 Million

Brian L Durkin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2023
SELL
Payment of exercise price or tax liability
$1,725,158 $154.28 p/Share
11,182 Reduced 25.22%
33,149 Common Stock, $0.01 pa...
Feb 16 2023
BUY
Grant, award, or other acquisition
-
25,237 Added 36.28%
44,331 Common Stock, $0.01 pa...
Mar 09 2022
SELL
Open market or private sale
$2,794,200 $150.0 p/Share
18,628 Reduced 49.38%
19,094 Common Stock, $0.01 pa...
Mar 09 2022
BUY
Exercise of conversion of derivative security
$923,112 $79.02 p/Share
11,682 Added 23.65%
37,722 Common Stock, $0.01 pa...
Feb 25 2022
SELL
Payment of exercise price or tax liability
$1,134,859 $149.54 p/Share
7,589 Reduced 22.57%
26,040 Common Stock, $0.01 pa...
Feb 17 2022
BUY
Grant, award, or other acquisition
-
17,124 Added 33.74%
33,629 Common Stock, $0.01 pa...
Dec 20 2021
SELL
Open market or private sale
$1,515,133 $128.51 p/Share
11,790 Reduced 41.67%
16,505 Common Stock, $0.01 pa...
Dec 20 2021
BUY
Exercise of conversion of derivative security
$440,565 $61.36 p/Share
7,180 Added 20.24%
28,295 Common Stock, $0.01 pa...
Feb 28 2021
SELL
Payment of exercise price or tax liability
$257,714 $107.74 p/Share
2,392 Reduced 10.18%
21,115 Common Stock, $0.01 pa...
Feb 18 2021
BUY
Grant, award, or other acquisition
-
8,169 Added 25.79%
23,507 Common Stock, $0.01 pa...
May 08 2020
BUY
Grant, award, or other acquisition
-
60 Added 0.34%
17,704 Common Stock, $0.01 pa...
Mar 30 2020
BUY
Open market or private purchase
$51,750 $69.0 p/Share
750 Added 4.26%
16,844 Common Stock, $0.01 pa...
Mar 20 2020
BUY
Open market or private purchase
$54,000 $67.5 p/Share
800 Added 4.74%
16,094 Common Stock, $0.01 pa...
Mar 18 2020
BUY
Open market or private purchase
$149,996 $68.18 p/Share
2,200 Added 12.58%
15,294 Common Stock, $0.01 pa...
Feb 28 2020
SELL
Payment of exercise price or tax liability
$165,800 $85.42 p/Share
1,941 Reduced 12.91%
13,094 Common Stock, $0.01 pa...
Feb 20 2020
BUY
Grant, award, or other acquisition
-
6,527 Added 30.27%
15,035 Common Stock, $0.01 pa...
Jul 25 2019
SELL
Payment of exercise price or tax liability
$41,353 $67.46 p/Share
613 Reduced 6.72%
8,508 Common Stock, $0.01 pa...
Mar 25 2019
SELL
Open market or private sale
$37,853 $79.69 p/Share
475 Reduced 4.95%
9,121 Common Stock, $0.01 pa...
Feb 28 2019
SELL
Payment of exercise price or tax liability
$60,193 $79.41 p/Share
758 Reduced 7.32%
9,596 Common Stock, $0.01 pa...
Feb 21 2019
BUY
Grant, award, or other acquisition
-
3,737 Added 26.52%
10,354 Common Stock, $0.01 pa...
BLD

Brian L Durkin

VP, CONTROLLER
North Chicago, IL

Track Institutional and Insider Activities on ABBV

Follow AbbVie Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABBV shares.

Notify only if

Insider Trading

Get notified when an Abb Vie Inc. insider buys or sells ABBV shares.

Notify only if

News

Receive news related to AbbVie Inc.

Track Activities on ABBV